Overview
Overview
Social Initiatives
Social Initiatives
Uganda
Preventive health care in Uganda: Mosquito nets to reduce the risk of malaria
In Uganda, Bayer is actively participating in the fight against the widespread disease malaria, which is transmitted by the Anopheles mosquito. The goal is to prevent or at least hinder the transmission process. To achieve this, Bayer is cooperating with the German Society for Technical Cooperation (GTZ) and local authorities to distribute mosquito nets treated with insecticides. In the view of the World Health Organization, this is an effective method of reducing the risk of infection. If the nets are left untreated, mosquitoes can still sting through them, whereas treatment with insecticides effectively prevents this.
Dealers who sell such nets were given extensive training to educate them of the advantages of this form of prevention. The same information was provided to the pubic health services in various regions of the country. A further information campaign was directed specifically at nurses, while a roadshow was undertaken to reach the general public.
Malaria is a major health problem in Uganda. Every fourth hospital visit is related to malaria infection, and the disease is the number one cause of death in children under five. That's why the fight against malaria is a high priority for the government and health authorities in this central African country.
The costs of the anti-malaria project are shared equally by Bayer and the GTZ. The company sees its participation in this project as a direct contribution to promoting health and fighting poverty in Uganda.
Between 300 and 500 million people become infected with malaria each year, and the disease almost exclusively affects developing countries. Of the one to three million people who die of malaria each year, most are children under five years of age. The demand for new treatment options is likely to continue to rise in the coming years due to increasing resistance to currently used medicines. About 2.5 billion people live in regions where there is a risk of contracting malaria.
Dealers who sell such nets were given extensive training to educate them of the advantages of this form of prevention. The same information was provided to the pubic health services in various regions of the country. A further information campaign was directed specifically at nurses, while a roadshow was undertaken to reach the general public.
Malaria is a major health problem in Uganda. Every fourth hospital visit is related to malaria infection, and the disease is the number one cause of death in children under five. That's why the fight against malaria is a high priority for the government and health authorities in this central African country.
The costs of the anti-malaria project are shared equally by Bayer and the GTZ. The company sees its participation in this project as a direct contribution to promoting health and fighting poverty in Uganda.
Between 300 and 500 million people become infected with malaria each year, and the disease almost exclusively affects developing countries. Of the one to three million people who die of malaria each year, most are children under five years of age. The demand for new treatment options is likely to continue to rise in the coming years due to increasing resistance to currently used medicines. About 2.5 billion people live in regions where there is a risk of contracting malaria.
Bookmark this page
E-mail this page
Global Compact:
to country overview
